Clinical utility of SARS-CoV-2 whole genome sequencing in deciphering source of infection
Coronavirus disease 2019 (COVID-19) caused by human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide problem. From the standpoint of hospital infection control, determining the source of infection is critical. We conducted the present study to evaluate the efficacy of usin...
Saved in:
Published in | The Journal of hospital infection Vol. 107; pp. 40 - 44 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.01.2021
Published by Elsevier Ltd on behalf of The Healthcare Infection Society |
Subjects | |
Online Access | Get full text |
ISSN | 0195-6701 1532-2939 1532-2939 |
DOI | 10.1016/j.jhin.2020.10.014 |
Cover
Abstract | Coronavirus disease 2019 (COVID-19) caused by human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide problem. From the standpoint of hospital infection control, determining the source of infection is critical. We conducted the present study to evaluate the efficacy of using whole genome sequencing to determine the source of infection in hospitalized patients who do not have a clear infectious contact history. Recently, we encountered two seemingly separate COVID-19 clusters in a tertiary hospital. Whole viral genome sequencing distinguished the two clusters according to the viral haplotype. However, the source of infection was unclear in 14 patients with COVID-19 who were clinically unlinked to clusters 1 or 2. These patients, who had no clear history of infectious contact within the hospital (‘undetermined source of infection’), had haplotypes similar to those in cluster 2 but did not have two of the mutations used to characterize cluster 2, suggesting that these 14 cases of ‘undetermined source of infection’ were not derived from cluster 2. Whole viral genome sequencing can be useful for confirming that sporadic COVID-19 cases with an undetermined source of infection are indeed not part of clusters at the institutional level. |
---|---|
AbstractList | Coronavirus disease 2019 (COVID-19) caused by human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide problem. From the standpoint of hospital infection control, determining the source of infection is critical. We conducted the present study to evaluate the efficacy of using whole genome sequencing to determine the source of infection in hospitalized patients who do not have a clear infectious contact history. Recently, we encountered two seemingly separate COVID-19 clusters in a tertiary hospital. Whole viral genome sequencing distinguished the two clusters according to the viral haplotype. However, the source of infection was unclear in 14 patients with COVID-19 who were clinically unlinked to clusters 1 or 2. These patients, who had no clear history of infectious contact within the hospital (‘undetermined source of infection’), had haplotypes similar to those in cluster 2 but did not have two of the mutations used to characterize cluster 2, suggesting that these 14 cases of ‘undetermined source of infection’ were not derived from cluster 2. Whole viral genome sequencing can be useful for confirming that sporadic COVID-19 cases with an undetermined source of infection are indeed not part of clusters at the institutional level. COVID-19 caused by SARS-CoV-2 is a worldwide problem. From the standpoint of hospital infection control, determining the source of infection is critical. We conducted the present study to evaluate the efficacy of using whole genome sequencing to determine the source of infection in hospitalized patients who do not have a clear infectious contact history. Recently, we encountered two seemingly separate COVID-19 clusters in a tertiary hospital. Whole viral genome sequencing distinguished the two clusters according to the viral haplotype. However, the source of infection was unclear in 14 patients with COVID-19 who were clinically unlinked to clusters #1 or #2. These patients, who had no clear history of infectious contact within the hospital ("undetermined source of infection"), had haplotypes similar to those in cluster #2 but did not have two of the mutations used to characterize cluster #2, suggesting that these 14 cases of "undetermined source of infection" were not derived from cluster #2. Whole viral genome sequencing can be useful for confirming that sporadic COVID-19 cases with an undetermined source of infection are indeed not part of clusters at the institutional level.COVID-19 caused by SARS-CoV-2 is a worldwide problem. From the standpoint of hospital infection control, determining the source of infection is critical. We conducted the present study to evaluate the efficacy of using whole genome sequencing to determine the source of infection in hospitalized patients who do not have a clear infectious contact history. Recently, we encountered two seemingly separate COVID-19 clusters in a tertiary hospital. Whole viral genome sequencing distinguished the two clusters according to the viral haplotype. However, the source of infection was unclear in 14 patients with COVID-19 who were clinically unlinked to clusters #1 or #2. These patients, who had no clear history of infectious contact within the hospital ("undetermined source of infection"), had haplotypes similar to those in cluster #2 but did not have two of the mutations used to characterize cluster #2, suggesting that these 14 cases of "undetermined source of infection" were not derived from cluster #2. Whole viral genome sequencing can be useful for confirming that sporadic COVID-19 cases with an undetermined source of infection are indeed not part of clusters at the institutional level. COVID-19 caused by SARS-CoV-2 is a worldwide problem. From the standpoint of hospital infection control, determining the source of infection is critical. We conducted the present study to evaluate the efficacy of using whole genome sequencing to determine the source of infection in hospitalized patients who do not have a clear infectious contact history. Recently, we encountered two seemingly separate COVID-19 clusters in a tertiary hospital. Whole viral genome sequencing distinguished the two clusters according to the viral haplotype. However, the source of infection was unclear in 14 patients with COVID-19 who were clinically unlinked to clusters #1 or #2. These patients, who had no clear history of infectious contact within the hospital ("undetermined source of infection"), had haplotypes similar to those in cluster #2 but did not have two of the mutations used to characterize cluster #2, suggesting that these 14 cases of "undetermined source of infection" were not derived from cluster #2. Whole viral genome sequencing can be useful for confirming that sporadic COVID-19 cases with an undetermined source of infection are indeed not part of clusters at the institutional level. SummaryCoronavirus disease 2019 (COVID-19) caused by human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide problem. From the standpoint of hospital infection control, determining the source of infection is critical. We conducted the present study to evaluate the efficacy of using whole genome sequencing to determine the source of infection in hospitalized patients who do not have a clear infectious contact history. Recently, we encountered two seemingly separate COVID-19 clusters in a tertiary hospital. Whole viral genome sequencing distinguished the two clusters according to the viral haplotype. However, the source of infection was unclear in 14 patients with COVID-19 who were clinically unlinked to clusters 1 or 2. These patients, who had no clear history of infectious contact within the hospital (‘undetermined source of infection’), had haplotypes similar to those in cluster 2 but did not have two of the mutations used to characterize cluster 2, suggesting that these 14 cases of ‘undetermined source of infection’ were not derived from cluster 2. Whole viral genome sequencing can be useful for confirming that sporadic COVID-19 cases with an undetermined source of infection are indeed not part of clusters at the institutional level. |
Author | Kosaki, K. Takenouchi, T. Fukunaga, K. Murata, M. Kitagawa, Y. Abe, K. Osada, A. Ishizu, H. Iwasaki, Y.W. Hasegawa, N. Uwamino, Y. Amagai, M. Uno, S. Saya, H. Siomi, H. Takebayashi, T. Harada, S. |
Author_xml | – sequence: 1 givenname: T. surname: Takenouchi fullname: Takenouchi, T. organization: Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan – sequence: 2 givenname: Y.W. surname: Iwasaki fullname: Iwasaki, Y.W. organization: Department of Molecular Biology, Keio University School of Medicine, Tokyo, Japan – sequence: 3 givenname: S. surname: Harada fullname: Harada, S. organization: Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan – sequence: 4 givenname: H. surname: Ishizu fullname: Ishizu, H. organization: Department of Molecular Biology, Keio University School of Medicine, Tokyo, Japan – sequence: 5 givenname: Y. surname: Uwamino fullname: Uwamino, Y. organization: Division of Infectious Diseases and Infection Control, Keio University Hospital, Tokyo, Japan – sequence: 6 givenname: S. surname: Uno fullname: Uno, S. organization: Division of Infectious Diseases and Infection Control, Keio University Hospital, Tokyo, Japan – sequence: 7 givenname: A. surname: Osada fullname: Osada, A. organization: Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan – sequence: 8 givenname: K. surname: Abe fullname: Abe, K. organization: Department of Surgery, Keio University School of Medicine, Tokyo, Japan – sequence: 9 givenname: N. surname: Hasegawa fullname: Hasegawa, N. organization: Division of Infectious Diseases and Infection Control, Keio University Hospital, Tokyo, Japan – sequence: 10 givenname: M. surname: Murata fullname: Murata, M. organization: Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan – sequence: 11 givenname: T. surname: Takebayashi fullname: Takebayashi, T. organization: Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan – sequence: 12 givenname: K. surname: Fukunaga fullname: Fukunaga, K. organization: Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan – sequence: 13 givenname: H. surname: Saya fullname: Saya, H. organization: Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan – sequence: 14 givenname: Y. surname: Kitagawa fullname: Kitagawa, Y. organization: Department of Surgery, Keio University School of Medicine, Tokyo, Japan – sequence: 15 givenname: M. surname: Amagai fullname: Amagai, M. organization: Department of Dermatology, Keio University School of Medicine, Tokyo, Japan – sequence: 16 givenname: H. surname: Siomi fullname: Siomi, H. email: awa403@keio.jp organization: Department of Molecular Biology, Keio University School of Medicine, Tokyo, Japan – sequence: 17 givenname: K. surname: Kosaki fullname: Kosaki, K. email: kkosaki@keio.jp organization: Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34756867$$D View this record in MEDLINE/PubMed |
BookMark | eNqFklFrFDEUhYNU7Lb6B3yQefRl1ptkkpkRKZTFqlAQXBV8CrPJnd2Ms8k2mansv2-G3YoWrE8hN_ecQ-53z8iJ8w4JeUlhToHKN92821g3Z8Cmwhxo8YTMqOAsZzWvT8gMaC1yWQI9JWcxdgCQ6uIZOeVFKWQlyxn5seits7rps3GwvR32mW-z5eWXZb7w33OW_dr4HrM1Or_FLOLNiE5bt86sywxqu9tgmK7Rj0HjpLWuRT1Y756Tp23TR3xxPM_Jt6v3Xxcf8-vPHz4tLq9zLSQd8qKSUBoAYSpJeQllU-qagxGI0mDR1pxTURgwGlfSCKhXhkkmUDMqoGSSn5OLg-9uXG0xtbkhNL3aBbttwl75xqq_X5zdqLW_VaWoRFGzZPD6aBB8-l8c1NZGjX3fOPRjVEzUEiivappaX_2Z9Tvkfp6poTo06OBjDNgqbYdmGkeKtr2ioCZ0qlMTOjWhm2oJXZKyB9J790dF7w4iTBO-tRhU1DYhQmNDwqCMt4_LLx7I9XEdfuIeY5eousROURWZArWcFmraJwYcilrwZPD23wb_S78DR0Hakg |
CitedBy_id | crossref_primary_10_1097_MD_0000000000028398 crossref_primary_10_1055_s_0041_1736561 crossref_primary_10_7883_yoken_JJID_2021_841 crossref_primary_10_1016_j_jhin_2023_08_002 crossref_primary_10_7717_peerj_13132 crossref_primary_10_2302_kjm_kjm_covid19_01 crossref_primary_10_1016_j_infpip_2021_100190 crossref_primary_10_1038_s41598_022_05424_3 crossref_primary_10_1016_j_jhin_2021_05_017 crossref_primary_10_7883_yoken_JJID_2023_464 crossref_primary_10_1016_j_jcv_2021_104877 crossref_primary_10_1016_j_tmaid_2021_102210 crossref_primary_10_7717_peerj_cs_1479 crossref_primary_10_1093_ofid_ofab120 crossref_primary_10_1093_infdis_jiad074 crossref_primary_10_2302_kjm_2021_0005_OA |
Cites_doi | 10.7883/yoken.JJID.2020.061 10.1093/bioinformatics/btp352 10.1016/j.cell.2020.06.043 10.15585/mmwr.mm6912e3 10.1093/bioinformatics/bty407 10.1186/s13059-018-1618-7 10.1002/gch2.1018 10.1038/s41586-020-2008-3 10.1016/j.ijid.2020.06.027 10.4161/fly.19695 10.1093/bioinformatics/btv566 10.1093/bioinformatics/btp324 |
ContentType | Journal Article |
Copyright | 2020 Copyright © 2020. Published by Elsevier Ltd. 2020 Published by Elsevier Ltd on behalf of The Healthcare Infection Society. 2020 |
Copyright_xml | – notice: 2020 – notice: Copyright © 2020. Published by Elsevier Ltd. – notice: 2020 Published by Elsevier Ltd on behalf of The Healthcare Infection Society. 2020 |
CorporateAuthor | Keio Donner Project |
CorporateAuthor_xml | – name: Keio Donner Project |
DBID | AAYXX CITATION NPM 7X8 5PM |
DOI | 10.1016/j.jhin.2020.10.014 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1532-2939 |
EndPage | 44 |
ExternalDocumentID | PMC7585492 34756867 10_1016_j_jhin_2020_10_014 S0195670120304953 1_s2_0_S0195670120304953 |
Genre | Journal Article |
GroupedDBID | --- --K --M ..I .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AAAJQ AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAWTL AAXKI AAXUO AAYWO ABAOU ABBQC ABFNM ABFRF ABJNI ABMAC ABMZM ABOCM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADGUI ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ARUGR ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG CJTIS COF CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEJ HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM L7B LUGTX M29 M41 MHUIS MO0 N9A O-L O9- OAUVE OD- OO. OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSI SSZ T5K UHS UV1 WOW WUQ Z5R ZGI ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AJBFU EFLBG LCYCR ZA5 AAYXX AGRNS CITATION NPM 7X8 ACLOT ~HD 5PM |
ID | FETCH-LOGICAL-c561t-48607d005d8613707a7c930d5ee6de4f933154d0dceb6d509bd2625ec21507263 |
IEDL.DBID | AIKHN |
ISSN | 0195-6701 1532-2939 |
IngestDate | Thu Aug 21 14:13:05 EDT 2025 Sat Sep 27 20:06:44 EDT 2025 Fri Apr 04 01:34:05 EDT 2025 Thu Apr 24 23:00:48 EDT 2025 Tue Jul 01 03:53:55 EDT 2025 Fri Feb 23 02:47:38 EST 2024 Tue Feb 25 20:08:53 EST 2025 Tue Aug 26 20:34:29 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | COVID-19 Nosocomial infection SARS-CoV-2 Community infection Whole genome sequencing |
Language | English |
License | Copyright © 2020. Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c561t-48607d005d8613707a7c930d5ee6de4f933154d0dceb6d509bd2625ec21507263 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work. |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7585492 |
PMID | 34756867 |
PQID | 2596013891 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7585492 proquest_miscellaneous_2596013891 pubmed_primary_34756867 crossref_citationtrail_10_1016_j_jhin_2020_10_014 crossref_primary_10_1016_j_jhin_2020_10_014 elsevier_sciencedirect_doi_10_1016_j_jhin_2020_10_014 elsevier_clinicalkeyesjournals_1_s2_0_S0195670120304953 elsevier_clinicalkey_doi_10_1016_j_jhin_2020_10_014 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-01-01 |
PublicationDateYYYYMMDD | 2021-01-01 |
PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | The Journal of hospital infection |
PublicationTitleAlternate | J Hosp Infect |
PublicationYear | 2021 |
Publisher | Elsevier Ltd Published by Elsevier Ltd on behalf of The Healthcare Infection Society |
Publisher_xml | – name: Elsevier Ltd – name: Published by Elsevier Ltd on behalf of The Healthcare Infection Society |
References | Moriarty, Plucinski, Marston, Kurbatova, Knust, Murray (bib13) 2020; 69 Quick (bib6) 2020; vol. 1 Li, Durbin (bib7) 2009; 25 Korber, Fischer, Gnanakaran, Yoon, Theiler, Abfalterer (bib14) 2020; 182 Grubaugh, Gangavarapu, Quick, Matteson, De Jesus, Main (bib9) 2019; 20 Okonechnikov, Conesa, Garcia-Alcalde (bib10) 2016; 32 Elbe, Buckland-Merrett (bib2) 2017; 1 Hadfield, Megill, Bell, Huddleston, Potter, Callender (bib3) 2018; 34 Wu, Zhao, Yu, Chen, Wang, Song (bib8) 2020; 579 Shirato, Nao, Katano, Takayama, Saito, Kato (bib4) 2020; 73 Cingolani, Platts, Wang le, Coon, Nguyen, Wang (bib12) 2012; 6 Artic ncov-2019 primers, version 3. 2020. Penarrubia, Ruiz, Porco, Rao, Juanola-Falgarona, Manissero (bib1) 2020; 97 Li, Handsaker, Wysoker, Fennell, Ruan, Homer (bib11) 2009; 25 Li (10.1016/j.jhin.2020.10.014_bib7) 2009; 25 Okonechnikov (10.1016/j.jhin.2020.10.014_bib10) 2016; 32 Korber (10.1016/j.jhin.2020.10.014_bib14) 2020; 182 Grubaugh (10.1016/j.jhin.2020.10.014_bib9) 2019; 20 Moriarty (10.1016/j.jhin.2020.10.014_bib13) 2020; 69 Cingolani (10.1016/j.jhin.2020.10.014_bib12) 2012; 6 Penarrubia (10.1016/j.jhin.2020.10.014_bib1) 2020; 97 10.1016/j.jhin.2020.10.014_bib5 Hadfield (10.1016/j.jhin.2020.10.014_bib3) 2018; 34 Shirato (10.1016/j.jhin.2020.10.014_bib4) 2020; 73 Wu (10.1016/j.jhin.2020.10.014_bib8) 2020; 579 Quick (10.1016/j.jhin.2020.10.014_bib6) 2020; vol. 1 Elbe (10.1016/j.jhin.2020.10.014_bib2) 2017; 1 Li (10.1016/j.jhin.2020.10.014_bib11) 2009; 25 |
References_xml | – volume: 32 start-page: 292 year: 2016 end-page: 294 ident: bib10 article-title: Qualimap 2: advanced multi-sample quality control for high-throughput sequencing data publication-title: Bioinformatics – volume: 73 start-page: 304 year: 2020 end-page: 307 ident: bib4 article-title: Development of genetic diagnostic methods for novel coronavirus 2019 (nCoV-2019) in Japan publication-title: Jpn J Infect Dis – volume: 579 start-page: 265 year: 2020 end-page: 269 ident: bib8 article-title: A new coronavirus associated with human respiratory disease in China publication-title: Nature – volume: 20 start-page: 8 year: 2019 ident: bib9 article-title: An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar publication-title: Genome Biol – volume: 69 start-page: 347 year: 2020 end-page: 352 ident: bib13 article-title: Public health responses to COVID-19 outbreaks on cruise ships – worldwide, February–March 2020 publication-title: Morb Mortal Wkly Rep – volume: 97 start-page: 225 year: 2020 end-page: 229 ident: bib1 article-title: Multiple assays in a real-time RT–PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak publication-title: Int J Infect Dis – volume: 34 start-page: 4121 year: 2018 end-page: 4123 ident: bib3 article-title: Nextstrain: real-time tracking of pathogen evolution publication-title: Bioinformatics – volume: vol. 1 year: 2020 ident: bib6 publication-title: nCoV-2019 sequencing protocol – volume: 6 start-page: 80 year: 2012 end-page: 92 ident: bib12 article-title: A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of publication-title: Fly (Austin) – volume: 25 start-page: 2078 year: 2009 end-page: 2079 ident: bib11 article-title: The Sequence Alignment/Map format and SAMtools publication-title: Bioinformatics – volume: 1 start-page: 33 year: 2017 end-page: 46 ident: bib2 article-title: Data, disease and diplomacy: GISAID’s innovative contribution to global health publication-title: Glob Chall – volume: 25 start-page: 1754 year: 2009 end-page: 1760 ident: bib7 article-title: Fast and accurate short read alignment with Burrows–Wheeler transform publication-title: Bioinformatics – volume: 182 start-page: 812 year: 2020 end-page: 827 e19 ident: bib14 article-title: Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus publication-title: Cell – reference: Artic ncov-2019 primers, version 3. 2020. – volume: 73 start-page: 304 year: 2020 ident: 10.1016/j.jhin.2020.10.014_bib4 article-title: Development of genetic diagnostic methods for novel coronavirus 2019 (nCoV-2019) in Japan publication-title: Jpn J Infect Dis doi: 10.7883/yoken.JJID.2020.061 – volume: 25 start-page: 2078 year: 2009 ident: 10.1016/j.jhin.2020.10.014_bib11 article-title: The Sequence Alignment/Map format and SAMtools publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp352 – volume: 182 start-page: 812 year: 2020 ident: 10.1016/j.jhin.2020.10.014_bib14 article-title: Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus publication-title: Cell doi: 10.1016/j.cell.2020.06.043 – volume: 69 start-page: 347 year: 2020 ident: 10.1016/j.jhin.2020.10.014_bib13 article-title: Public health responses to COVID-19 outbreaks on cruise ships – worldwide, February–March 2020 publication-title: Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm6912e3 – volume: 34 start-page: 4121 year: 2018 ident: 10.1016/j.jhin.2020.10.014_bib3 article-title: Nextstrain: real-time tracking of pathogen evolution publication-title: Bioinformatics doi: 10.1093/bioinformatics/bty407 – volume: 20 start-page: 8 year: 2019 ident: 10.1016/j.jhin.2020.10.014_bib9 article-title: An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar publication-title: Genome Biol doi: 10.1186/s13059-018-1618-7 – volume: 1 start-page: 33 year: 2017 ident: 10.1016/j.jhin.2020.10.014_bib2 article-title: Data, disease and diplomacy: GISAID’s innovative contribution to global health publication-title: Glob Chall doi: 10.1002/gch2.1018 – volume: 579 start-page: 265 year: 2020 ident: 10.1016/j.jhin.2020.10.014_bib8 article-title: A new coronavirus associated with human respiratory disease in China publication-title: Nature doi: 10.1038/s41586-020-2008-3 – volume: 97 start-page: 225 year: 2020 ident: 10.1016/j.jhin.2020.10.014_bib1 article-title: Multiple assays in a real-time RT–PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2020.06.027 – volume: 6 start-page: 80 year: 2012 ident: 10.1016/j.jhin.2020.10.014_bib12 article-title: A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3 publication-title: Fly (Austin) doi: 10.4161/fly.19695 – volume: 32 start-page: 292 year: 2016 ident: 10.1016/j.jhin.2020.10.014_bib10 article-title: Qualimap 2: advanced multi-sample quality control for high-throughput sequencing data publication-title: Bioinformatics doi: 10.1093/bioinformatics/btv566 – volume: vol. 1 year: 2020 ident: 10.1016/j.jhin.2020.10.014_bib6 – volume: 25 start-page: 1754 year: 2009 ident: 10.1016/j.jhin.2020.10.014_bib7 article-title: Fast and accurate short read alignment with Burrows–Wheeler transform publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp324 – ident: 10.1016/j.jhin.2020.10.014_bib5 |
SSID | ssj0009395 |
Score | 2.42233 |
Snippet | Coronavirus disease 2019 (COVID-19) caused by human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide problem. From the standpoint of... SummaryCoronavirus disease 2019 (COVID-19) caused by human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide problem. From the... COVID-19 caused by SARS-CoV-2 is a worldwide problem. From the standpoint of hospital infection control, determining the source of infection is critical. We... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 40 |
SubjectTerms | Community infection COVID-19 Infectious Disease Nosocomial infection SARS-CoV-2 Short Report Whole genome sequencing |
Title | Clinical utility of SARS-CoV-2 whole genome sequencing in deciphering source of infection |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0195670120304953 https://www.clinicalkey.es/playcontent/1-s2.0-S0195670120304953 https://dx.doi.org/10.1016/j.jhin.2020.10.014 https://www.ncbi.nlm.nih.gov/pubmed/34756867 https://www.proquest.com/docview/2596013891 https://pubmed.ncbi.nlm.nih.gov/PMC7585492 |
Volume | 107 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED9t3QsSQnxTPiYj8Ya8xnZip49VxVSo2MPKYDxZSexumUZa0U688bdzFzuFMhgST5Ecn2Jfzr7f2fcB8MqkPsuFF1wVyZwTYOelyQuuDZospanyQlCA8_sjPTlJ351mpzsw7mJhyK0y7v1hT29369gyiNwcLOt6MGtD3QwFf9JVUaZ2YU-its97sDd6O50c_cy9q4ZZV5aQCGLsTHDzujivKQ2qpIaDRKR_00_X8efvbpS_6KXDu3AnAko2CmO-Bzu-uQ-3w2kcC0FGD-BzTP95yVDOCHizxZzNRsczPl585JJ9oyq5jPK1fvEselejTmN1w5yv6mUbJHjGwkk_0XY-XM1DODl882E84bGoAq8QKq05FZ0yDteey1GTm8QUphqqxGXea-fT-VApRFUuwVmV2iGcKJ1EG8lXkqCj1OoR9JpF458AEyXqfi2cz9GoKrwssd88rTJkrBNpJfogOlbaKmYcp8IXl7ZzLbuwxH5L7Kc2ZH8fXm9oliHfxo29VfeHbBdJinufRXVwI5X5E5VfxeW7ssKupE3sNRHrQ7ah3JLSf37xZSc-Fpcv3ckUjV9crSxanzpcFvfhcRCnzbxVajKda4Pj3RK0TQdKDb79pqnP2xThZAWmQ_n0P8f7DG5J8t1pj5qeQ2_99cq_QPC1Lvdh9-C72I9LjJ7T40_TH9bfLdk |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-N7gEkhPimfBqJNxQaf8ROH6uKqWNbH-iGxpOVxC7LNNKKduLf5y52CmUwJF4dn-Jc7ny_s-8D4I1RPsu554ks0nlCgD0pTV4k2qDLUpoqLzglOB9N9eREfTjNTndg3OXCUFhl3PvDnt7u1nFkELk5WNb1YNamuhlK_qSrokzegF1FTa17sDvaP5hMf9belcOsa0tIBDF3JoR5nZ_VVAZV0MC7lKu_2aer-PP3MMpf7NLeXbgTASUbhTXfgx3f3Ifb4TSOhSSjB_A5lv-8YChnBLzZYs5mo4-zZLz4lAj2nbrkMqrX-tWzGF2NNo3VDXO-qpdtkuAXFk76ibaL4Woewsne--PxJIlNFZIKodI6oaZTxqHuuRwtuUlNYaqhTF3mvXZezYdSIqpyKX5VqR3CidIJ9JF8JQg6Ci0fQa9ZNP4JMF6i7dfc-RydqsKLEufNVZUhYx1XFe8D71hpq1hxnBpfXNgutOzcEvstsZ_GkP19eLuhWYZ6G9fOlt0fsl0mKe59Fs3BtVTmT1R-FdV3ZbldCZvaKyLWh2xDuSWl_3zj6058LKov3ckUjV9crix6nzpcFvfhcRCnzXdLZTKda4Pr3RK0zQQqDb79pKnP2hLh5AWqoXj6n-t9BTcnx0eH9nB_evAMbgmK42mPnZ5Db_3t0r9AILYuX0ZF-wF9my4c |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+utility+of+SARS-CoV-2+whole+genome+sequencing+in+deciphering+source+of+infection&rft.jtitle=The+Journal+of+hospital+infection&rft.au=Takenouchi%2C+T.&rft.au=Iwasaki%2C+Y.W.&rft.au=Harada%2C+S.&rft.au=Ishizu%2C+H.&rft.date=2021-01-01&rft.pub=Elsevier+Ltd&rft.issn=0195-6701&rft.eissn=1532-2939&rft.volume=107&rft.spage=40&rft.epage=44&rft_id=info:doi/10.1016%2Fj.jhin.2020.10.014&rft.externalDocID=S0195670120304953 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01956701%2Fcov200h.gif |